Infection control, genetic assessment of drug resistance and drug susceptibility testing in the current management of multidrug/extensively-resistant tuberculosis (M/XDR-TB) in Europe: A tuberculosis network European Trialsgroup (TBNET) study-Reference-Cited by-同舟云学术

Infection control, genetic assessment of drug resistance and drug susceptibility testing in the current management of multidrug/extensively-resistant tuberculosis (M/XDR-TB) in Europe: A tuberculosis network European Trialsgroup (TBNET) study

Published:2017-11 Issue: Volume:132 Page:68-75
ISSN:0954-6111
Container-title:Respiratory Medicine
language:en
Short-container-title:Respiratory Medicine

Author:

Bothamley Graham H.,Lange Christoph,Albrecht Dirk,Anibarro Luis^ORCID,Gomez Neus Altet,Andersen Aase Bengaard,Avsar Korkut,Balasanyants Goar,Belton Moerida^ORCID,García Cristina Berastegui,Bogyi Matthias^ORCID,Bruchfeld Judith,Caminero Jose,Chesov Dumitru^ORCID,Chiappini Elena,Confalonieri Marco,Dedicoat Martin,Luiza de Souza Galvao Maria^ORCID,Duarte Raquel,Dudnyk Andrii^ORCID,Dyrhol-Riise Anne Ma,Eisenhut Michael,Esteban Jaime,Fløe Andreas,García-García José-María^ORCID,Giacomet Vania,Gomez-Pastrana David,Gyorfy Zsuzsanna,Holmoka Jiri,Jachym Mathilde Fréchet^ORCID,Janssens Jean-Paul,Jonsson Jerker,Kaluzhenina Anna^ORCID,Konstantynovska Olha^ORCID,Kruczak Katarzyna,Ladeira Inês,Kuksa Liga,Kulcitkaia Stela^ORCID,Lillebæk Troels,Magis-Escurra Cecile^ORCID,Manika Katerina,Joan-Pau Millet^ORCID,Muylle Inge^ORCID,Palmieri Fabrizio,Pesut Dragica,Polanova Monika,Pontali Emanuele,Popa Cristina,Ravn Pernille,Sánchez-Montalvá Adrian,Schoch Otto^ORCID,Selmeryd Ingrid,Skrahina Alena,Solovic Ivan,Soriano-Arandes Antoni^ORCID,Thouvenin Guillaume,Tiberi Simon,Wagner Dirk,van der Werf Tjip,van Ingen Jakko,Vicente Diego,Volchenkov Grigory^ORCID,Woltmann Gerrit^ORCID

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference23 articles.

1. Global Tuberculosis Report;World Health Organization,2015

2. TB and MDR/XDR-TB in the EU and EEA/EFTA countries: managed or mismanaged;Migliori;Eur. Respir. J.,2012

3. TB and M/XDR-TB infection control in European TB reference centres: the Achilles' heel;Sotgiu;Eur. Respir. J.,2011

4. TBNET. Availability, price and affordability of anti-tuberculosis drugs in Europe: a TBNET survey;Günther;Eur. Respir. J.,2015

5. TBNET. Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement;Lange;Eur. Respir. J.,2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibiotic resistance acquisition versus primary transmission in the presentation of extensively drug-resistant tuberculosis;International Journal of Mycobacteriology;2022

2. Health system influences on the implementation of tuberculosis infection prevention and control at health facilities in low-income and middle-income countries: a scoping review;BMJ Global Health;2021-05

3. Use and impact of molecular methods for detecting drug‐resistant TB;The International Journal of Tuberculosis and Lung Disease;2021-02-01

4. Discordant line probe genotypic testing vs culture-based drug susceptibility phenotypic testing in TB endemic KwaZulu-Natal: Impact on bedside clinical decision making;Journal of Clinical Tuberculosis and Other Mycobacterial Diseases;2020-08

5. Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline;American Journal of Respiratory and Critical Care Medicine;2019-11-15